NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that GE HealthCare Technologies Inc. (Nasdaq: GEHC), will become a component of the Nasdaq-100 Index® (Nasdaq: NDX), the Nasdaq-100 Equal Weighted Index (Nasdaq: NDXE), and the Nasdaq-100 Ex-Tech Sector Index (Nasdaq: NDXX) prior to market open on Wednesday, June 7, 2023. GE HealthCare Technologies Inc. will replace Fiserv, Inc. (Nasdaq: FISV) in the Nasdaq-100 Index®, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex-Tech Sector Index. Fiserv, Inc. will also be removed from the Nasdaq-100 ESG Index (Nasdaq: NDXESG) prior to market open on Wednesday, June 7, 2023.
For more information about the company, go to https://www.gehealthcare.com/.
About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com.
The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq’s proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
Media Contact: | Camille Stafford, Nasdaq | |
Issuer & Investor Contact: | Index Client Services, Nasdaq | |
This email address is being protected from spambots. You need JavaScript enabled to view it. |
Last Trade: | US$75.20 |
Daily Change: | 0.59 0.79 |
Daily Volume: | 2,930,085 |
Market Cap: | US$34.430B |
June 23, 2025 June 19, 2025 June 12, 2025 June 02, 2025 |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load